Theseus Pharmaceuticals, which aimed to overcome the resistance that cancers develop to drugs, is laying off most of its staff and exploring options that could lead to deals that eke out some value ...
-- Company prioritizing THE-349, a potentially best-in-class fourth-generation EGFR inhibitor for EGFR mutant non-small cell lung cancer; IND on track for submission in Q4 2023 -- -- Theseus announces ...
It’s been a wild November for Theseus Pharmaceuticals. Just a couple of weeks ago, the biotech laid off almost three-quarters of its staff. Days later, the company received offers from two sets of ...
Feedback has been flooded with answers (both correct and inspired) after wondering if there is a word for something that is ...
Warning: This post discusses theories that could be potential spoilers for Fantastic Beasts: The Crimes of Grindelwald.Plenty of Harry Potter characters have names that are connected to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results